PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jnmaLink to Publisher's site
 
J Natl Med Assoc. 2007 October; 99(10): 1170–1184.
PMCID: PMC2574407

Leiomyomata uteri: hormonal and molecular determinants of growth.

Abstract

OBJECTIVE: To review the available English literature that examines the biology of leiomyoma uteri in African-American women and other ethnic groups. Factors that influence the growth and development of leiomyomas are examined to understand the basis for larger myomas in African-American women. DESIGN: Literature review of 176 articles regarding the pathobiology of leiomyoma in various ethnic groups. RESULTS: The initiating factor(s) associated with the transformation of a normal myometrial cell into a leiomyoma cell remain(s) to be determined. Epidemiological studies have confirmed that different ethnic groups develop leiomyomas. However, African-American ethnicity is a risk factor for the development of leiomyomas. Studies have examined diet, genetics, hormonal, growth, enzymatic and molecular determinants of myoma biology, with critical advances in some of these areas. The best radiological tools to identify and monitor leiomyomas are ultrasonography and/or magnetic resonance imaging. Evidence supports progesterone and growth factors (e.g., transforming growth factor-B), have significant impact on the development of leiomyomas. CONCLUSIONS: Early monitoring and intervention should become standard for African-American women who are at greater risk for developing leiomyomas. There are plausible biological mechanisms that explain the predisposition for developing larger leiomyomas in African-American women as compared with other ethnic groups.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (4.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • MILLER NF, LUDOVICI PP. On the origin and development of uterine fibroids. Am J Obstet Gynecol. 1955 Oct;70(4):720–740. [PubMed]
  • Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):14–18. [PubMed]
  • Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect. 2000 Oct;108 (Suppl 5):791–793. [PubMed]
  • Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol. 1998 Oct;92(4 Pt 1):624–627. [PubMed]
  • Richards PA, Tiltman AJ. Anatomical variation of the oestrogen receptor in the non-neoplastic myometrium of fibromyomatous uteri. Virchows Arch. 1996 Aug;428(6):347–351. [PubMed]
  • Flake Gordon P, Andersen Janet, Dixon Darlene. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003 Jun;111(8):1037–1054. [PMC free article] [PubMed]
  • Nibert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer. 1990 May;2(1):3–13. [PubMed]
  • Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol. 1991 Jun;77(6):923–926. [PubMed]
  • Mashal RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sklar J. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer. 1994 Sep;11(1):1–6. [PubMed]
  • Andersen J, Barbieri RL. Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Investig. 1995 Sep-Oct;2(5):663–672. [PubMed]
  • Baschinsky DY, Isa A, Niemann TH, Prior TW, Lucas JG, Frankel WL. Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol. 2000 Nov;31(11):1429–1432. [PubMed]
  • Ligon AH, Morton CC. Leiomyomata: heritability and cytogenetic studies. Hum Reprod Update. 2001 Jan-Feb;7(1):8–14. [PubMed]
  • Rein MS, Powell WL, Walters FC, Weremowicz S, Cantor RM, Barbieri RL, Morton CC. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod. 1998 Jan;4(1):83–86. [PubMed]
  • Skubitz Keith M, Skubitz Amy P N. Differential gene expression in uterine leiomyoma. J Lab Clin Med. 2003 May;141(5):297–308. [PubMed]
  • Tsibris John C M, Segars James, Coppola Domenico, Mane Shrikant, Wilbanks George D, O'Brien William F, Spellacy William N. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril. 2002 Jul;78(1):114–121. [PubMed]
  • Wang Hongbo, Mahadevappa Mamatha, Yamamoto Karen, Wen Yan, Chen Bertha, Warrington Janet A, Polan Mary Lake. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril. 2003 Aug;80(2):266–276. [PubMed]
  • Weston Gareth, Trajstman Albert C, Gargett Caroline E, Manuelpillai Ursula, Vollenhoven Beverley J, Rogers Peter A W. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod. 2003 Sep;9(9):541–549. [PubMed]
  • Wei Jian-Jun, Chiriboga Luis, Mittal Khush. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril. 2005 Aug;84(2):474–484. [PubMed]
  • Sandberg Avery A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. Cancer Genet Cytogenet. 2005 Apr 1;158(1):1–26. [PubMed]
  • Catherino William H, Leppert Phyllis C, Stenmark Matthew H, Payson Mark, Potlog-Nahari Clariss, Nieman Lynnette K, Segars James H. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer. 2004 Jul;40(3):204–217. [PubMed]
  • Leppert Phyllis C, Catherino William H, Segars James H. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006 Aug;195(2):415–420. [PubMed]
  • Baird Donna Day, Dunson David B, Hill Michael C, Cousins Deborah, Schectman Joel M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100–107. [PubMed]
  • Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS., Jr Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab. 1988 Aug;67(2):334–340. [PubMed]
  • Andersen J, DyReyes VM, Barbieri RL, Coachman DM, Miksicek RJ. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures. J Soc Gynecol Investig. 1995 May-Jun;2(3):542–551. [PubMed]
  • DeWaay Deborah J, Syrop Craig H, Nygaard Ingrid E, Davis William A, Van Voorhis Bradley J. Natural history of uterine polyps and leiomyomata. Obstet Gynecol. 2002 Jul;100(1):3–7. [PubMed]
  • Ryan Ginny L, Syrop Craig H, Van Voorhis Bradley J. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005 Jun;48(2):312–324. [PubMed]
  • Uimari Outi, Suomalainen-König Sanna, Sakkinen Nina, Santala Markku, Nieminen Pentti, Ryynanen Markku. Natural history of familial myomas. Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):255–258. [PubMed]
  • Wallach Edward E, Vlahos Nikos F. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004 Aug;104(2):393–406. [PubMed]
  • Roth Ted M, Gustilo-Ashby Tara, Barber Matthew D, Myers Evan R. Effects of race and clinical factors on short-term outcomes of abdominal myomectomy. Obstet Gynecol. 2003 May;101(5 Pt 1):881–884. [PubMed]
  • Sozen Ibrahim, Arici Aydin. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril. 2002 Jul;78(1):1–12. [PubMed]
  • Toro Jorge R, Nickerson Michael L, Wei Ming-Hui, Warren Michelle B, Glenn Gladys M, Turner Maria L, Stewart Laveta, Duray Paul, Tourre Ousman, Sharma Nirmala, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003 Jul;73(1):95–106. [PubMed]
  • Heinemann Klaas, Thiel Christine, Möhner Sabine, Lewis Michael A, Raff Thorsten, Kühl-Habich Dörthe, Heinemann Lothar A J. Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health. Eur J Obstet Gynecol Reprod Biol. 2003 Mar 26;107(1):78–80. [PubMed]
  • Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand. 2000 Mar;79(3):202–207. [PubMed]
  • Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, Olive D. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod. 2004 Oct;19(10):2350–2355. [PubMed]
  • Sato Fumio, Mori Mitsuru, Nishi Motoi, Kudo Ryuichi, Miyake Hirotsugu. Familial aggregation of uterine myomas in Japanese women. J Epidemiol. 2002 May;12(3):249–253. [PubMed]
  • Brett Kate M, Higgins Jenny A. Hysterectomy prevalence by Hispanic ethnicity: evidence from a national survey. Am J Public Health. 2003 Feb;93(2):307–312. [PubMed]
  • Aboyeji AP, Ijaiya MA. Uterine fibroids: a ten-year clinical review in Ilorin, Nigeria. Niger J Med. 2002 Jan-Mar;11(1):16–19. [PubMed]
  • Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997 Dec;90(6):967–973. [PubMed]
  • Chen CR, Buck GM, Courey NG, Perez KM, Wactawski-Wende J. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol. 2001 Jan 1;153(1):20–26. [PubMed]
  • Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol. 2001 Jan 1;153(1):1–10. [PubMed]
  • Baird Donna Day, Dunson David B, Hill Michael C, Cousins Deborah, Schectman Joel M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100–107. [PubMed]
  • Wise Lauren A, Palmer Julie R, Stewart Elizabeth A, Rosenberg Lynn. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005 Mar;105(3):563–568. [PMC free article] [PubMed]
  • Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990 Oct;94(4):435–438. [PubMed]
  • Myers Evan R, Barber Matthew D, Gustilo-Ashby Tara, Couchman Grace, Matchar David B, McCrory Douglas C. Management of uterine leiomyomata: what do we really know? Obstet Gynecol. 2002 Jul;100(1):8–17. [PubMed]
  • Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, Stampfer MJ, Hunter DJ. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 1998 Sep;70(3):432–439. [PubMed]
  • Wise Lauren A, Palmer Julie R, Harlow Bernard L, Spiegelman Donna, Stewart Elizabeth A, Adams-Campbell Lucile L, Rosenberg Lynn. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004 Jan 15;159(2):113–123. [PMC free article] [PubMed]
  • Kjerulff KH, Guzinski GM, Langenberg PW, Stolley PD, Moye NE, Kazandjian VA. Hysterectomy and race. Obstet Gynecol. 1993 Nov;82(5):757–764. [PubMed]
  • Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996 Jul;41(7):483–490. [PubMed]
  • Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol. 2001 Jun;44(2):316–326. [PubMed]
  • Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 1986 Aug 9;293(6543):359–362. [PMC free article] [PubMed]
  • Palomba Stefano, Sena Teresa, Morelli Michele, Noia Roberto, Zullo Fulvio, Mastrantonio Pasquale. Effect of different doses of progestin on uterine leiomyomas in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2002 May 10;102(2):199–201. [PubMed]
  • Woods MN, Barnett JB, Spiegelman D, Trail N, Hertzmark E, Longcope C, Gorbach SL. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst. 1996 Oct 2;88(19):1369–1374. [PubMed]
  • Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine myomas. Obstet Gynecol. 1999 Sep;94(3):395–398. [PubMed]
  • Jung BH, Bai SW, Chung BC. Endogenous urinary steroids in premenopausal women with uterine leiomyomas. Int J Gynaecol Obstet. 2004 Jan;84(1):55–60. [PubMed]
  • Rosati P, Exacoustòs C, Mancuso S. Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study. J Ultrasound Med. 1992 Oct;11(10):511–515. [PubMed]
  • Strobelt N, Ghidini A, Cavallone M, Pensabene I, Ceruti P, Vergani P. Natural history of uterine leiomyomas in pregnancy. J Ultrasound Med. 1994 May;13(5):399–401. [PubMed]
  • Neiger Ran, Sonek Jiri D, Croom Christopher S, Ventolini Gary. Pregnancy-related changes in the size of uterine leiomyomas. J Reprod Med. 2006 Sep;51(9):671–674. [PubMed]
  • Hammoud Ahmad O, Asaad Radwan, Berman Jay, Treadwell Marjorie C, Blackwell Sean, Diamond Michael P. Volume change of uterine myomas during pregnancy: do myomas really grow? J Minim Invasive Gynecol. 2006 Sep-Oct;13(5):386–390. [PubMed]
  • Yang CH, Lee JN, Hsu SC, Kuo CH, Tsai EM. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study. Maturitas. 2002 Sep 30;43(1):35–39. [PubMed]
  • Spellacy WN, Le Maire WJ, Buhi WC, Birk SA, Bradley BA. Plasma growth hormone and estradiol levels in women with uterine myomas. Obstet Gynecol. 1972 Dec;40(6):829–834. [PubMed]
  • Maheux R, Lemay-Turcot L, Lemay A. Daily follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone in ten women harboring uterine leiomyomas. Fertil Steril. 1986 Aug;46(2):205–208. [PubMed]
  • Dawood MY, Khan-Dawood FS. Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas. Fertil Steril. 1994 Apr;61(4):617–621. [PubMed]
  • Otubu JA, Buttram VC, Besch NF, Besch PK. Unconjugated steroids in leiomyomas and tumor-bearing myometrium. Am J Obstet Gynecol. 1982 May 15;143(2):130–133. [PubMed]
  • Folkerd EJ, Newton CJ, Davidson K, Anderson MC, James VH. Aromatase activity in uterine leiomyomata. J Steroid Biochem. 1984 May;20(5):1195–1200. [PubMed]
  • Newton CJ, James VH. 17 beta-hydroxysteroid dehydrogenase activity in leiomyoma and myometrium and its relationship to concentrations of oestrone, oestradiol and progesterone throughout the menstrual cycle. J Steroid Biochem. 1985 Apr;22(4):487–493. [PubMed]
  • Pasqualini JR, Cornier E, Grenier J, Vella C, Schatz B, Netter A. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium. Fertil Steril. 1990 Jun;53(6):1012–1017. [PubMed]
  • Puukka MJ, Kontula KK, Kauppila AJ, Janne OA, Vihko RK. Estrogen receptor in human myoma tissue. Mol Cell Endocrinol. 1976 Nov;6(1):35–44. [PubMed]
  • Farber M, Conrad S, Heinrichs WL, Herrmann WL. Estradiol binding by fibroid tumors and normal myometrium. Obstet Gynecol. 1972 Oct;40(4):479–486. [PubMed]
  • Soules MR, McCarty KS., Jr Leiomyomas: steroid receptor content. Variation within normal menstrual cycles. Am J Obstet Gynecol. 1982 May 1;143(1):6–11. [PubMed]
  • Tamaya T, Fujimoto J, Okada H. Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium. Acta Obstet Gynecol Scand. 1985;64(4):307–309. [PubMed]
  • Sadan O, van Iddekinge B, van Gelderen CJ, Savage N, Becker PJ, van der Walt LA, Robinson M. Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium. Ann Clin Biochem. 1987 May;24(Pt 3):263–267. [PubMed]
  • Sadan O, van Iddekinge B, Savage N, Robinson M, Zakut H. Ethnic variation in estrogen and progesterone receptor concentration in leiomyoma and normal myometrium. Gynecol Endocrinol. 1988 Dec;2(4):275–282. [PubMed]
  • Amant Frédéric, Huys Erik, Geurts-Moespot Anneke, Lindeque BG, Vergote Ignace, Sweep Fred, Schoenmakers Eric F P M. Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels. J Soc Gynecol Investig. 2003 Feb;10(2):105–109. [PubMed]
  • Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril. 1990 Jun;53(6):1018–1023. [PubMed]
  • Kawaguchi K, Fujii S, Konishi I, Iwai T, Nanbu Y, Nonogaki H, Ishikawa Y, Mori T. Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch A Pathol Anat Histopathol. 1991;419(4):309–315. [PubMed]
  • Brandon DD, Bethea CL, Strawn EY, Novy MJ, Burry KA, Harrington MS, Erickson TE, Warner C, Keenan EJ, Clinton GM. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 1993 Jul;169(1):78–85. [PubMed]
  • Pedeutour F, Quade BJ, Weremowicz S, Dal Cin P, Ali S, Morton CC. Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata. Genes Chromosomes Cancer. 1998 Dec;23(4):361–366. [PubMed]
  • Andersen J. Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium. Environ Health Perspect. 2000 Oct;108 (Suppl 5):811–815. [PubMed]
  • Gargett Caroline E, Bucak Kristina, Zaitseva Marina, Chu Simon, Taylor Nancy, Fuller Peter J, Rogers Peter A W. Estrogen receptor-alpha and -beta expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Mol Hum Reprod. 2002 Aug;8(8):770–775. [PubMed]
  • Büchi KA, Keller PJ. Cytoplasmic progestin receptors in myomal and myometrial tissues. Concentrations and hormonal dependency. Acta Obstet Gynecol Scand. 1983;62(5):487–492. [PubMed]
  • Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson JA. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 1997 Dec;82(12):4258–4265. [PubMed]
  • Sakaguchi Hideki, Fujimoto Jiro, Aoki Ikumi, Tamaya Teruhiko. Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids. 2003 Jan;68(1):11–19. [PubMed]
  • Jakimiuk Artur J, Bogusiewicz Michal, Tarkowski Rafal, Dziduch Piotr, Adamiak Aneta, Wróbel Andrzej, Haczyński Józef, Magoffin Denis A, Jakowicki Jerzy A. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril. 2004 Oct;82 (Suppl 3):1244–1249. [PubMed]
  • Kovács KA, Oszter A, Göcze PM, Környei JL, Szabó I. Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium. Mol Hum Reprod. 2001 Nov;7(11):1085–1091. [PubMed]
  • Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, Warner C, Clinton GM. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 1995 Jun;80(6):1876–1881. [PubMed]
  • Lessl M, Klotzbuecher M, Schoen S, Reles A, Stöckemann K, Fuhrmann U. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium. J Clin Endocrinol Metab. 1997 Aug;82(8):2596–2600. [PubMed]
  • Valladares Francisco, Frías Ignacio, Báez Delia, García Candelaria, López Francisco J, Fraser James D, Rodríguez Yurena, Reyes Ricardo, Díaz-Flores Lucio, Bello Aixa R. Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells. Fertil Steril. 2006 Dec;86(6):1736–1743. [PubMed]
  • Wei Jian-Jun, Chiriboga Luis, Arslan Alan A, Melamed Jonathan, Yee Herman, Mittal Khush. Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod. 2006 Jan;21(1):57–67. [PubMed]
  • Tiltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol. 1985;4(2):89–96. [PubMed]
  • Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berliere M, Donnez J. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Hum Reprod. 1999 Nov;14(11):2844–2850. [PubMed]
  • Zasławski R, Surowiak P, Dziegiel P, Pretnik L, Zabel M. Analysis of the expression of estrogen and progesteron receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle. Med Sci Monit. 2001 Sep-Oct;7(5):908–913. [PubMed]
  • Viville B, Charnock-Jones DS, Sharkey AM, Wetzka B, Smith SK. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum Reprod. 1997 Apr;12(4):815–822. [PubMed]
  • Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990 May;9(5):1603–1614. [PubMed]
  • Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol. 1993 Oct;7(10):1244–1255. [PubMed]
  • Wen DX, Xu YF, Mais DE, Goldman ME, McDonnell DP. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994 Dec;14(12):8356–8364. [PMC free article] [PubMed]
  • Kraus WL, Weis KE, Katzenellenbogen BS. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol Cell Biol. 1995 Apr;15(4):1847–1857. [PMC free article] [PubMed]
  • Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod. 1996 Feb;54(2):287–293. [PubMed]
  • Murphy AA, Morales AJ, Kettel LM, Yen SS. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil Steril. 1995 Jul;64(1):187–190. [PubMed]
  • Chen Wei, Ohara Noriyuki, Wang Jiayin, Xu Qin, Liu Jin, Morikawa Akira, Sasaki Hiroko, Yoshida Shigeki, Demanno Deborah A, Chwalisz Kristof, et al. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab. 2006 Apr;91(4):1296–1304. [PubMed]
  • Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 2004 May-Jun;10(3):207–220. [PubMed]
  • Kurachi O, Matsuo H, Samoto T, Maruo T. Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone. J Clin Endocrinol Metab. 2001 May;86(5):2275–2280. [PubMed]
  • Sozen Ibrahim, Arici Aydin. Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors. Obstet Gynecol Clin North Am. 2006 Mar;33(1):41–58. [PubMed]
  • Ignotz RA, Massagué J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986 Mar 25;261(9):4337–4345. [PubMed]
  • Arici A, Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril. 2000 May;73(5):1006–1011. [PubMed]
  • Amant Frédéric, Dorfling Cecilia M, de Brabanter Jos, Vandewalle Joos, Vergote Ignace, Lindeque BG, van Rensburg Elizabeth J. A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. Acta Obstet Gynecol Scand. 2004 Mar;83(3):234–239. [PubMed]
  • Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res. 1998 Feb 15;58(4):585–587. [PubMed]
  • Denschlag Dominik, Bentz Eva-Katrin, Hefler Lukas, Pietrowski Detlef, Zeillinger Robert, Tempfer Clemens, Tong Dan. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril. 2006 Feb;85(2):462–467. [PubMed]
  • Hsieh Yao-Yuan, Chang Chi-Chen, Tsai Fuu-Jen, Tsai Horng-Der, Yeh Lian-Shun, Lin Cheng-Chieh, Tsai Chang-Hai. Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril. 2003 Jan;79(1):96–99. [PubMed]
  • Al-Hendy Ayman, Salama Salama A. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006 Feb;13(2):136–144. [PubMed]
  • Al-Hendy Ayman, Salama Salama A. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril. 2006 Sep;86(3):686–693. [PubMed]
  • Shozu M, Sumitani H, Segawa T, Yang HJ, Murakami K, Inoue M. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate. J Clin Endocrinol Metab. 2001 Nov;86(11):5405–5411. [PubMed]
  • Shozu Makio, Sumitani Hiroshi, Segawa Tomoya, Yang Hei-Juan, Murakami Kouichi, Kasai Tadayuki, Inoue Masaki. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J Clin Endocrinol Metab. 2002 Jun;87(6):2540–2548. [PubMed]
  • Shozu Makio, Murakami Kouichi, Segawa Tomoya, Kasai Tadayuki, Inoue Masaki. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril. 2003 Mar;79(3):628–631. [PubMed]
  • Bulun SE, Simpson ER, Word RA. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab. 1994 Mar;78(3):736–743. [PubMed]
  • Kasai Tadayuki, Shozu Makio, Murakami Kouichi, Segawa Tomoya, Shinohara Kazunori, Nomura Kazuhito, Inoue Masaki. Increased expression of type I 17beta-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma. J Clin Endocrinol Metab. 2004 Nov;89(11):5661–5668. [PubMed]
  • van de Ven Joost, Donker Truus H, Blankenstein Marinus A, Thijssen Joseph H. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium. Fertil Steril. 2002 Jun;77(6):1227–1232. [PubMed]
  • Marsh Erica E, Bulun Serdar E. Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am. 2006 Mar;33(1):59–67. [PubMed]
  • Bourlev Vladimir, Pavlovitch Stanislav, Stygar Denis, Volkov Nikolai, Lindblom Bo, Olovsson Matts. Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas. Gynecol Obstet Invest. 2003;55(4):199–204. [PubMed]
  • Pavlovich SV, Volkov NI, Burlev VA. Proliferative activity and level of steroid hormone receptors in the myometrium and myoma nodes in different phases of menstrual cycle. Bull Exp Biol Med. 2003 Oct;136(4):396–398. [PubMed]
  • Wei Jian-Jun, Zhang Xing-Min, Chiriboga Luis, Yee Herman, Perle Mary A, Mittal Khush. Spatial differences in biologic activity of large uterine leiomyomata. Fertil Steril. 2006 Jan;85(1):179–187. [PubMed]
  • Wei Jian-Jun, Chiriboga Luis, Mittal Khush. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril. 2005 Aug;84(2):474–484. [PubMed]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association